Beijing Chunlizhengda Medical Instruments Co., Ltd. (688236.SS)
CNY 13.6
(-1.16%)
CNY 13.6
(-1.16%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 340.92 Million CNY | -23.66% |
| 2022 | 367.29 Million CNY | -11.04% |
| 2021 | 386.16 Million CNY | 21.18% |
| 2020 | 345.15 Million CNY | 14.52% |
| 2019 | 285.14 Million CNY | 141.35% |
| 2018 | 124.19 Million CNY | 37.25% |
| 2017 | 87.51 Million CNY | 11.42% |
| 2016 | 79.81 Million CNY | 91.63% |
| 2015 | 48.44 Million CNY | -9.08% |
| 2014 | 48.02 Million CNY | 12.3% |
| 2013 | 42.11 Million CNY | 9.56% |
| 2012 | 40.33 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | -16.9 Million CNY | -152.4% |
| 2024 Q1 | 92.55 Thousand CNY | -99.92% |
| 2024 Q2 | 13.97 Million CNY | 34753.01% |
| 2023 Q1 | 61.75 Million CNY | -52.92% |
| 2023 FY | - CNY | -23.66% |
| 2023 Q2 | 69.41 Million CNY | 12.41% |
| 2023 Q4 | 99.04 Million CNY | 82.51% |
| 2023 Q3 | 54.26 Million CNY | -21.83% |
| 2022 Q1 | 86.97 Million CNY | -36.63% |
| 2022 Q4 | 131.17 Million CNY | 322.79% |
| 2022 Q3 | 31.02 Million CNY | -63.51% |
| 2022 Q2 | 85.03 Million CNY | -2.24% |
| 2022 FY | - CNY | -11.04% |
| 2021 FY | - CNY | 21.18% |
| 2021 Q3 | -121.08 Million CNY | -218.42% |
| 2021 Q4 | 137.25 Million CNY | 213.36% |
| 2021 Q1 | 82.42 Million CNY | -13.88% |
| 2021 Q2 | 102.24 Million CNY | 24.05% |
| 2020 Q3 | 95.71 Million CNY | -5.6% |
| 2020 FY | - CNY | 14.52% |
| 2020 Q4 | 95.71 Million CNY | 0.0% |
| 2020 Q2 | 101.38 Million CNY | 145.27% |
| 2020 Q1 | 41.33 Million CNY | -46.48% |
| 2019 Q3 | 77.23 Million CNY | 23.73% |
| 2019 Q2 | 62.42 Million CNY | -0.0% |
| 2019 Q4 | 77.23 Million CNY | 0.0% |
| 2019 Q1 | 62.42 Million CNY | 91.06% |
| 2019 FY | - CNY | 141.35% |
| 2018 Q2 | 27.91 Million CNY | -0.0% |
| 2018 FY | - CNY | 37.25% |
| 2018 Q4 | 32.67 Million CNY | 0.0% |
| 2018 Q3 | 32.67 Million CNY | 17.02% |
| 2018 Q1 | 27.91 Million CNY | 39.81% |
| 2017 Q3 | 19.96 Million CNY | -3.54% |
| 2017 Q2 | 20.7 Million CNY | -0.0% |
| 2017 FY | - CNY | 11.42% |
| 2017 Q4 | 19.96 Million CNY | 0.0% |
| 2017 Q1 | 20.7 Million CNY | 40.56% |
| 2016 Q2 | 20.76 Million CNY | -0.0% |
| 2016 FY | - CNY | 91.63% |
| 2016 Q3 | 14.72 Million CNY | -29.07% |
| 2016 Q1 | 20.76 Million CNY | 210.78% |
| 2016 Q4 | 14.72 Million CNY | 0.0% |
| 2015 Q4 | 6.68 Million CNY | 0.0% |
| 2015 Q2 | 14.92 Million CNY | 0.0% |
| 2015 Q3 | 6.68 Million CNY | -55.24% |
| 2015 Q1 | 14.92 Million CNY | -18.36% |
| 2015 FY | - CNY | -9.08% |
| 2014 Q4 | 18.28 Million CNY | 0.0% |
| 2014 Q2 | 12.11 Million CNY | -0.0% |
| 2014 Q1 | 12.11 Million CNY | -31.88% |
| 2014 FY | - CNY | 12.3% |
| 2013 Q4 | 17.78 Million CNY | 0.0% |
| 2013 FY | - CNY | 9.56% |
| 2012 FY | - CNY | 0.0% |